Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment


argenx obtained a €2.5 million grant to develop antibody-based therapies

argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies, received a €2.5 million grant from Flanders Innovation and Entrepreneurship (VLAIO).

Covance creates a global immunology and immunotoxicology unit

LabCorp, a leading global life sciences company, announced that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.
cancer lab diagnostic

Russian scientists developed technology for biocompatible implants manufacturing

Researchers said that biocompatible implants might be widely used in medicine for replacing body tissues and elements of vital internal organs ranging from finger joints to heart valves.

Ruspharmtech has received U.S. patent for cancer drug alofanib

Russian Pharmaceutical Technologies (Ruspharmtech, a SKOLKOVO resident) has increased the commercial value of its patent portfolio by obtaining a US patent.

Merus and Ono Pharmaceutical extended their collaboration

Merus N.V., a Dutch clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that Ono Pharmaceutical has exercised its option to enter into a new research and license agreement

Irkutsk scientists synthesized a substance that protects against flu virus

Researchers at the Irkutsk Institute of Chemistry of the Siberian Branch of the Russian Academy of Sciences synthesized a substance that protects against flu virus, including H1N1, better known as swine flu.

Russian scientists are developing phytobiotics for livestock farming

The scientists at the Kemerovo State Agricultural Institute are developing phytobiotics from Siberian herbs; it is expected that the drugs would be able to replace similar imported additives and antibiotics

Russian Ministry of Industry and Trade mentions the great potential of Rosatom

Rosatom State Corporation has the capacity for developing the medical part of its activities. This opinion was expressed by Sergey Tsyb, the Deputy Minister of Industry and Trade of the Russian Federation.


Expert opinion